Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$2.17 - $4.3 $30,067 - $59,580
-13,856 Reduced 56.12%
10,834 $32,000
Q2 2022

Aug 09, 2022

BUY
$1.81 - $8.93 $44,688 - $220,481
24,690 New
24,690 $47,000
Q2 2021

Sep 17, 2021

SELL
$9.77 - $15.33 $99,654 - $156,366
-10,200 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$10.51 - $17.46 $107,202 - $178,092
10,200 New
10,200 $155,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.